LOINC
Version 2.68

LP28643-2Carcinoembryonic AgActive

Descriptions

LP28643-2   Carcinoembryonic Ag
Carcinoembryonic antigen (CEA), a tumor-associated oncofetal antigen, is a member of the immunoglobulin gene super family. CEA results differ depending on the techniques used and are not always comparable. Increased CEA values are seen with cancer of the colon, rectum, lung, breast, liver, pancreas, stomach, and ovary. Pre-operative CEA values correlate with prognosis and metastasis development in patients with colorectal cancer. Serial measurements have 80% sensitivity and 70% specificity for detecting recurrence. Smaller increases in CEA may occur with benign liver disease, benign breast disease, pulmonary infection, emphysema, and renal failure. Information from Tietz Clinical Guide to Laboratory Tests,4th Ed, AHB Wu, 2006. Source: Regenstrief Institute

LP28643-2   Carcinoembryonic Ag
Carcinoembryonic antigen (CEA) is a protein normally found in the tissue of a developing fetus. The blood level of CEA drops significantly or disappears after birth. In adults, an abnormal level of CEA may indicate cancer, and smoking may increase CEA. The CEA blood test measures the level of CEA in blood to monitor responses to treatment and check for the return of colon, medullary thyroid, rectum, lung, breast, liver, pancreas, stomach, and ovarian cancer. [MedlinePlus Encyclopedia:003574] Source: Regenstrief LOINC

Basic Part Properties

Name
Carcinoembryonic Ag
Type
Component
Created On
2001-11-21
Construct for LOINC Short Name
CEA

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP28643-2

Language Variants Get Info

zh-CNChinese (CHINA)
癌胚抗原
Synonyms: CEA;癌胚 Ag;癌胚抗原(Carcinoembryonic Antigen,CEA)